Biosimilars vs. Interchangeable Biological Products: FDA Fact Check
XTalks
FEBRUARY 8, 2021
As a subset of biosimilars, interchangeable biological products can be substituted for the reference product at the pharmacy level, without the input of the prescribing physician. MYTH: Clinical pharmacology studies of biosimilars aim to establish safety and effectiveness. What is an Interchangeable Biological Product?
Let's personalize your content